search
Back to results

High Intensity Interval Training (HIIT) to Reduce Frailty and Enhance Resilience in Older Veterans (HIIT@Home)

Primary Purpose

Frailty

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Center based attention control
Center based HIIT
Home based HIIT
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Frailty focused on measuring aging, frailty, veteran, functional capacity, resilience, cognition, sleep

Eligibility Criteria

60 Years - 85 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Ages 60 years Male and female, any race Medically cleared for exercise Non-frail or pre-frail (frailty score < 3) Exclusion Criteria: Severe co-morbidity: COPD (GOLD stage IV), CKD ( stage 3)), severe HTN (180 mmHg/120 mmHg) VA-SLUMS score 20 (Cognition)

Sites / Locations

  • Kansas City VA Medical Center, Kansas City, MO
  • Kansas City VA Medical Center, Kansas City, MO

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Center based attention control

Center based HIIT

Home based HIIT

Arm Description

Center based attention control

Center based HIIT

Home based HIIT

Outcomes

Primary Outcome Measures

Short Physical Performance Battery
The short physical performance battery (SPPB) is a battery of test often used in geriatric research to capture functional capacity in older adults. The test includes a balance and coordination assessment via asking participants to hold stances with three different foot positions (side-by-side, semi-tandem, and tandem: score 0-4), a gait speed test of approximately 10 feet (score 0-4 based on time), and a chair rise timed test where a participant is asked to rise from a chair 5 times (score 0-4 based on time). The composite score is therefore 0 to 12.
Frailty assessment
Frailty is a syndrome marked by greater susceptibility to adverse outcomes like falls and disability. We will be using the Fried Frailty Phenotype that includes: 1) unexpected weight loss of 5% or more in the last year or BMI < 18.5; score 0 or 1 if positive, 2) grip strength with BMI dependent cut points for men and women; score 0 or 1 if positive, 3) gait speed with height and sex dependent cutoffs; score 0 or 1 if positive, 4) activity assessed by a survey of the frequency of mild/moderate/energetic physical activity; score of 0 or 1, the latter if positive for hardly ever or never engaging in moderate or energetic physical activity, and 5) endurance assessed by survey of bed rest during the day; score of 0 or 1, the latter if occurring every day or every week. The composite score is therefore 0 to 5.
Maximal oxygen uptake test (VO2max)
Participants are asked to exercise on an upright exercise bike as the resistance increases over time. During the exercise, participants are asked to breath through a mask that is connected to a oxygen and carbon dioxide measuring device. The assessment last for approximately 5-10 minutes and provides data the pertain to an individuals lung capacity, breathing rate, and endurance.
Gait speed
Participants are asked to perform a timed walk of approximately 15 feet in length
Muscle strength
Leg and arm strength will be measured using a small handheld dynamometer where the device is placed on the wrist or ankle as the participant is asked to extend or contract the limb with full force.
Quality of life assessment
Quality of life assessment is performed using the Quality of life, enjoyment, and satisfaction questionnaire - short form (Q-LES-Q-SF) survey instrument. The survey instrument scores from 0 to 70 with a greater score representing better quality of life.
Body Composition (Lean and fat mass)
Body composition will be measured using bioelectric impedance (BIA) - a technique where participants are asked to stand on the measurement device and hold on to two metal handles. A light - and non-detectable - current is then transmitted allowing for collection of body fat and lean mass in the subject. The assessment takes roughly 2-3 minutes.
Step counts
Objectively measure activity using FITBIT Charge 5 actigraphy devices. These devices are worn on the wrist and capture total steps.
C-Reactive Protein
Chronic inflammation may be indicative of distress and lead to chronic diseases. The study will examine the change in C-reactive protein in picograms per milliliter in serum from baseline to endpoint at 12 weeks.
Interleukin-6
Chronic inflammation may be indicative of distress and lead to chronic diseases. The study will examine the change in interleukin-6 in picograms per milliliter in serum from baseline to endpoint at 12 weeks.
Interleukin-10
Chronic inflammation may be indicative of distress and lead to chronic diseases. The study will examine the change in interleukin-10 in picograms per milliliter in serum from baseline to endpoint at 12 weeks.

Secondary Outcome Measures

Cognitive screen - SLUMS
Cognitive status will be assessed using the VA - St. Louis University Mental Survey (VA-SLUMS) involving memory tests, shape recognition, and story recall. The survey scores range from 0-30, with a higher score representing greater cognitive capability. We will also utilize the Cognivue to assess cognition. This is a combinatorial visual and reaction time test.
Amyloid beta 42/40 ratio
Serum cognitive marker: change in amyloid beta 42/40 ratio (a unitless measure derived from the ratio of serum amyloid-beta 42 in picograms per milliliter divided by serum amyloid-beta 40 in picograms per milliliter) from baseline to endpoint after 12 weeks.
Cognitive screen - Cognivue
Cognivue to assess cognition. This is a computer based combinatorial visual and reaction time test, which is scored 0 to 100.
Phosphorylated tau (P-tau)
Serum cognitive marker: plasma levels of phosphorylated tau (P-tau) in picograms per milliliter from baseline to endpoint after 12 weeks.
Brain Derived Neurotrophic Factor (BDNF)
Serum cognitive marker: change in Brain Derived Neurotrophic Factor (BDNF) in picograms per milliliter from baseline to endpoint after 12 weeks.
Fatigue
Fatigue as assessed by the Brief Fatigue Inventory, which contains 9 self-rated questions with an aggregate score range of 0 to 90.
Sleep quantity and stages
Objectively measure sleep quantity and stages using FITBIT Charge 5 actigraphy devices. These devices are worn on the wrist and sleep metrics, including total sleep time and time spent in light, deep, and REM sleep stages.
Sleep quality
Sleep quality as assessed by Pittsburgh Sleep Quality Index (PSQI). The PSQI contains 19 self-rated questions that combined to form 7 component scores, each with a range of 0 to 3 points. These in turn are added to yield a global score with a range of 0 to 21 points.
Sleep chronotype
Sleep chronotype as assessed by the Morningness/Eveningness survey, which contains 19 self-rated questions with an aggregate score range of 19 to 72.
Sleepiness
Sleepiness as assessed by the Epworth Sleepiness Scale, which contains 8 self-rated questions with an aggregate score range of 0 to 24.
Insomnia
Insomnia as assessed by the Insomnia Severity Index, which contains 7 self-rated questions with an aggregate score range of 0 to 28.
Anxiety and depression
Anxiety and depression as assessed by the Hospital Anxiety and Depression Scale (HADS), which contains 14 self-rated questions with an aggregate score range of 0 to 21.
Sleep disorders
Sleep disorders as assessed by the Holland Sleep Disorders Questionnaire, which contains 32 self-rated questions with an aggregate score range of 32 and 160.

Full Information

First Posted
November 14, 2022
Last Updated
October 6, 2023
Sponsor
VA Office of Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT05625204
Brief Title
High Intensity Interval Training (HIIT) to Reduce Frailty and Enhance Resilience in Older Veterans
Acronym
HIIT@Home
Official Title
High Intensity Interval Training (HIIT) to Reduce Frailty and Enhance Resilience in Older Veterans
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 1, 2023 (Anticipated)
Primary Completion Date
December 31, 2027 (Anticipated)
Study Completion Date
December 31, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Frailty is defined as a greater susceptibility to stressors resulting from age-related impairments in adaptive biological systems. Frailty leads to poorer physical performance and functional capacity and higher risk of adverse outcomes including falls, hospitalization, and mortality. Resilience, defined as the capacity to recover from disruptions to homeostasis, is critical to successful aging because it precedes frailty and enhances adults' ability to maintain optimal health and function well into older age. Evidence- based therapies to help older adults enhance resilience are limited and the biological underpinnings contributing to improved resilience have not yet been fully characterized. To address this important need, the investigators will conduct a clinical trial to examine the benefits of center- and home-based high intensity interval training (HIIT) on functional capacity, frailty, and resilience, and also to identify novel biomarkers of resilience in older Veterans.
Detailed Description
Impact of Home-Based High Intensity Interval Training on Resilience in Older Veterans More than 30% of U.S. Veterans 65 years or older are frail, which is three-times higher than in non-Veterans in the same age group. Frailty is defined as an increased susceptibility to stressors resulting from age-related impairments in adaptive biological systems, leading to higher risk of adverse outcomes including falls, disability, hospitalization, and mortality. Further, frailty prevalence increases with age, affecting 50% of all adults 85 and over. Resilience, which is defined as the capacity to recover from stress-induced disruptions to homeostasis, is critical to successful aging because it precedes frailty and presents an opportunity to intervene on early health deficits, thus preventing aging-related decline in health, function, and quality of life. Evidence-based therapies that enhance resilience in older adults are limited and the complex biological and physiological mechanisms underlying resilience are not yet fully understood. Consequently, Veterans seeking to boost their ability to recover from late-life stressors and prevent frailty have few proven options. The investigators overarching aim is to characterize the complex factors contributing to resilience and develop novel strategies that enhance resilience to boost health span in older adults. Towards this end, the investigators previous VA RR&D SPiRE Award allowed us to demonstrate the feasibility of 12-weeks of high intensity interval training (HIIT) among older Veterans. The investigators successfully enrolled and retained older male and female Veterans and safely conducted individually tailored HIIT that improved cardiorespiratory fitness, lower-body endurance, cognition, and quality of life. The purpose of the proposed larger trial is to build upon the investigators previous successes and develop and implement practical HIIT regimens to reduce frailty and enhance resilience in older Veterans. The investigators will conduct a randomized controlled trial to ascertain the therapeutic benefits of 12-weeks of center- and home-based HIIT on recovery and resilience among Veterans 60 years or older. The investigators have identified a series of biomarkers of resilience and are also seeking to examine key biological drivers of recovery at the molecular level. The investigators proposed study will not only identify feasible methods to measure resilience in older Veterans but will also assess the benefits of home-based HIIT on physical and cognitive performance, frailty, resilience, and health span.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Frailty
Keywords
aging, frailty, veteran, functional capacity, resilience, cognition, sleep

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Center based attention control
Arm Type
Experimental
Arm Description
Center based attention control
Arm Title
Center based HIIT
Arm Type
Experimental
Arm Description
Center based HIIT
Arm Title
Home based HIIT
Arm Type
Experimental
Arm Description
Home based HIIT
Intervention Type
Behavioral
Intervention Name(s)
Center based attention control
Intervention Description
Center based attention control
Intervention Type
Behavioral
Intervention Name(s)
Center based HIIT
Intervention Description
Center based HIIT
Intervention Type
Behavioral
Intervention Name(s)
Home based HIIT
Intervention Description
Home based HIIT
Primary Outcome Measure Information:
Title
Short Physical Performance Battery
Description
The short physical performance battery (SPPB) is a battery of test often used in geriatric research to capture functional capacity in older adults. The test includes a balance and coordination assessment via asking participants to hold stances with three different foot positions (side-by-side, semi-tandem, and tandem: score 0-4), a gait speed test of approximately 10 feet (score 0-4 based on time), and a chair rise timed test where a participant is asked to rise from a chair 5 times (score 0-4 based on time). The composite score is therefore 0 to 12.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Frailty assessment
Description
Frailty is a syndrome marked by greater susceptibility to adverse outcomes like falls and disability. We will be using the Fried Frailty Phenotype that includes: 1) unexpected weight loss of 5% or more in the last year or BMI < 18.5; score 0 or 1 if positive, 2) grip strength with BMI dependent cut points for men and women; score 0 or 1 if positive, 3) gait speed with height and sex dependent cutoffs; score 0 or 1 if positive, 4) activity assessed by a survey of the frequency of mild/moderate/energetic physical activity; score of 0 or 1, the latter if positive for hardly ever or never engaging in moderate or energetic physical activity, and 5) endurance assessed by survey of bed rest during the day; score of 0 or 1, the latter if occurring every day or every week. The composite score is therefore 0 to 5.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Maximal oxygen uptake test (VO2max)
Description
Participants are asked to exercise on an upright exercise bike as the resistance increases over time. During the exercise, participants are asked to breath through a mask that is connected to a oxygen and carbon dioxide measuring device. The assessment last for approximately 5-10 minutes and provides data the pertain to an individuals lung capacity, breathing rate, and endurance.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Gait speed
Description
Participants are asked to perform a timed walk of approximately 15 feet in length
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Muscle strength
Description
Leg and arm strength will be measured using a small handheld dynamometer where the device is placed on the wrist or ankle as the participant is asked to extend or contract the limb with full force.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Quality of life assessment
Description
Quality of life assessment is performed using the Quality of life, enjoyment, and satisfaction questionnaire - short form (Q-LES-Q-SF) survey instrument. The survey instrument scores from 0 to 70 with a greater score representing better quality of life.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Body Composition (Lean and fat mass)
Description
Body composition will be measured using bioelectric impedance (BIA) - a technique where participants are asked to stand on the measurement device and hold on to two metal handles. A light - and non-detectable - current is then transmitted allowing for collection of body fat and lean mass in the subject. The assessment takes roughly 2-3 minutes.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Step counts
Description
Objectively measure activity using FITBIT Charge 5 actigraphy devices. These devices are worn on the wrist and capture total steps.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
C-Reactive Protein
Description
Chronic inflammation may be indicative of distress and lead to chronic diseases. The study will examine the change in C-reactive protein in picograms per milliliter in serum from baseline to endpoint at 12 weeks.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Interleukin-6
Description
Chronic inflammation may be indicative of distress and lead to chronic diseases. The study will examine the change in interleukin-6 in picograms per milliliter in serum from baseline to endpoint at 12 weeks.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Interleukin-10
Description
Chronic inflammation may be indicative of distress and lead to chronic diseases. The study will examine the change in interleukin-10 in picograms per milliliter in serum from baseline to endpoint at 12 weeks.
Time Frame
Change from baseline to endpoint at 12 weeks
Secondary Outcome Measure Information:
Title
Cognitive screen - SLUMS
Description
Cognitive status will be assessed using the VA - St. Louis University Mental Survey (VA-SLUMS) involving memory tests, shape recognition, and story recall. The survey scores range from 0-30, with a higher score representing greater cognitive capability. We will also utilize the Cognivue to assess cognition. This is a combinatorial visual and reaction time test.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Amyloid beta 42/40 ratio
Description
Serum cognitive marker: change in amyloid beta 42/40 ratio (a unitless measure derived from the ratio of serum amyloid-beta 42 in picograms per milliliter divided by serum amyloid-beta 40 in picograms per milliliter) from baseline to endpoint after 12 weeks.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Cognitive screen - Cognivue
Description
Cognivue to assess cognition. This is a computer based combinatorial visual and reaction time test, which is scored 0 to 100.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Phosphorylated tau (P-tau)
Description
Serum cognitive marker: plasma levels of phosphorylated tau (P-tau) in picograms per milliliter from baseline to endpoint after 12 weeks.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Brain Derived Neurotrophic Factor (BDNF)
Description
Serum cognitive marker: change in Brain Derived Neurotrophic Factor (BDNF) in picograms per milliliter from baseline to endpoint after 12 weeks.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Fatigue
Description
Fatigue as assessed by the Brief Fatigue Inventory, which contains 9 self-rated questions with an aggregate score range of 0 to 90.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Sleep quantity and stages
Description
Objectively measure sleep quantity and stages using FITBIT Charge 5 actigraphy devices. These devices are worn on the wrist and sleep metrics, including total sleep time and time spent in light, deep, and REM sleep stages.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Sleep quality
Description
Sleep quality as assessed by Pittsburgh Sleep Quality Index (PSQI). The PSQI contains 19 self-rated questions that combined to form 7 component scores, each with a range of 0 to 3 points. These in turn are added to yield a global score with a range of 0 to 21 points.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Sleep chronotype
Description
Sleep chronotype as assessed by the Morningness/Eveningness survey, which contains 19 self-rated questions with an aggregate score range of 19 to 72.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Sleepiness
Description
Sleepiness as assessed by the Epworth Sleepiness Scale, which contains 8 self-rated questions with an aggregate score range of 0 to 24.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Insomnia
Description
Insomnia as assessed by the Insomnia Severity Index, which contains 7 self-rated questions with an aggregate score range of 0 to 28.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Anxiety and depression
Description
Anxiety and depression as assessed by the Hospital Anxiety and Depression Scale (HADS), which contains 14 self-rated questions with an aggregate score range of 0 to 21.
Time Frame
Change from baseline to endpoint at 12 weeks
Title
Sleep disorders
Description
Sleep disorders as assessed by the Holland Sleep Disorders Questionnaire, which contains 32 self-rated questions with an aggregate score range of 32 and 160.
Time Frame
Change from baseline to endpoint at 12 weeks

10. Eligibility

Sex
All
Gender Based
Yes
Gender Eligibility Description
157 male and 43 female participants divided equally between non-frail and pre-frail individuals, based upon Fried frailty criteria.
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Ages 60 years Male and female, any race Medically cleared for exercise Non-frail or pre-frail (frailty score < 3) Exclusion Criteria: Severe co-morbidity: COPD (GOLD stage IV), CKD ( stage 3)), severe HTN (180 mmHg/120 mmHg) VA-SLUMS score 20 (Cognition)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kenneth L Seldeen, PhD
Phone
(716) 888-4869
Email
Kenneth.Seldeen@va.gov
First Name & Middle Initial & Last Name or Official Title & Degree
Bruce R Troen, MD
Phone
(816) 922-2755
Email
Bruce.Troen@va.gov
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bruce R. Troen, MD
Organizational Affiliation
Kansas City VA Medical Center, Kansas City, MO
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kansas City VA Medical Center, Kansas City, MO
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64128-2226
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ramratan R Sharma, PhD MHSA
Phone
816-922-2757
Email
ram.sharma2@va.gov
First Name & Middle Initial & Last Name & Degree
Bruce R. Troen, MD
Facility Name
Kansas City VA Medical Center, Kansas City, MO
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64128
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bruce R Troen, MD
Email
bruce.troen@va.gov
First Name & Middle Initial & Last Name & Degree
Kenneth L Seldeen, PhD
Email
Kenneth.seldeen@va.gov

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Final data sets will be made available upon specific request and under an authorized Data Use Agreement. This, in addition to the publications being made available via PubMed Central, will enable validation of results by recipients.
IPD Sharing Time Frame
After analysis and completion of study along with subsequent publication of results.
IPD Sharing Access Criteria
After analysis and completion of study along with subsequent publication of results.

Learn more about this trial

High Intensity Interval Training (HIIT) to Reduce Frailty and Enhance Resilience in Older Veterans

We'll reach out to this number within 24 hrs